ANTIBODY FORMULATION IN HISTIDINE-ACETATE BUFFER

The present application describes antibody formulations, including monoclonal antibodies formulated in histidine-acetate buffer, as well as a formulation comprising an antibody that binds to domain II of HER2 (for example, Pertuzumab), and a formulation comprising an antibody that binds to DR5 (for...

Full description

Saved in:
Bibliographic Details
Main Authors LIU, JUN, GWEE, SHIANG, C, SHEN, YE, ANDYA, JAMES, D
Format Patent
LanguageEnglish
French
Published 31.08.2006
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present application describes antibody formulations, including monoclonal antibodies formulated in histidine-acetate buffer, as well as a formulation comprising an antibody that binds to domain II of HER2 (for example, Pertuzumab), and a formulation comprising an antibody that binds to DR5 (for example, Apomab). L'invention concerne des formulations d'anticorps, y compris des anticorps monoclonaux formulés dans un tampon d'histidine-acétate, ainsi qu'une formulation comprenant un anticorps qui se lie au domaine II de HER2 (par exemple le pertuzumab), et une formulation comprenant un anticorps qui se lie à DR5 (par exemple l'apomab).
Bibliography:Application Number: WO2005US37471